CytoMed Therapeutics (GDTC) Short Interest Ratio & Short Volume → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free GDTC Stock Alerts $2.18 -0.08 (-3.54%) (As of 11:26 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media CytoMed Therapeutics Short Interest DataCurrent Short Volume42,900 sharesPrevious Short Volume39,400 sharesChange Vs. Previous Month+8.88%Dollar Volume Sold Short$90,519.00Short Interest Ratio / Days to Cover3.0Last Record DateApril 30, 2024Outstanding Shares10,940,000 sharesFloat Size3,960,000 sharesShort Percent of Float1.08%Today's Trading Volume3,960 sharesAverage Trading Volume25,319 sharesToday's Volume Vs. Average16% Short Selling CytoMed Therapeutics ? Sign up to receive the latest short interest report for CytoMed Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGDTC Short Interest Over TimeGDTC Days to Cover Over TimeGDTC Percentage of Float Shorted Over Time Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WayNanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront!See how with its ongoing expansion and development CytoMed Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202442,900 shares $90,519.00 +8.9%1.1%3 $2.11 4/15/202439,400 shares $79,588.00 +11.6%1.0%1.6 $2.02 3/31/202435,300 shares $76,601.00 +82.9%0.9%1.2 $2.17 3/15/202419,300 shares $41,109.00 No Change0.5%0.4 $2.13 2/29/202419,300 shares $38,793.00 -15.7%0.5%0.4 $2.01 2/15/202422,900 shares $57,479.00 +593.9%0.6%0.4 $2.51 Get the Latest News and Ratings for GDTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytoMed Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,300 shares $11,682.00 -58.2%0.1%0.1 $3.54 1/15/20247,900 shares $32,627.00 -54.3%0.2%0.2 $4.13 12/31/202317,300 shares $84,770.00 +1,135.7%0.4%0.5 $4.90 12/15/20231,400 shares $4,746.00 -63.2%0.0%0.1 $3.39 11/30/20233,800 shares $14,022.00 +245.5%0.1%0.6 $3.69 11/15/20231,100 shares $4,411.00 -54.2%0.0%0.2 $4.01 10/31/20232,400 shares $8,952.00 -50.0%0.1%0.2 $3.73 10/15/20234,800 shares $16,944.00 -20.0%0.1%0.3 $3.53 9/30/20236,000 shares $21,000.00 -25.9%0.2%0 $3.50 9/15/20238,100 shares $30,456.00 -5.8%0.2%0 $3.76 8/31/20238,600 shares $28,982.00 +30.3%0.2%0 $3.37 8/15/20236,600 shares $24,882.00 -50.0%0.2%0 $3.77 7/31/202313,200 shares $57,156.00 -92.2%0.3%0 $4.33 7/15/2023169,600 shares $736,064.00 +198.6%4.3%0.3 $4.34 6/30/202356,800 shares $173,240.00 +24.6%1.5%0.1 $3.05 6/15/202345,600 shares $129,504.00 -27.2%1.2%0.3 $2.84 5/31/202362,600 shares $170,898.00 +67.8%1.8%0.3 $2.73 5/15/202337,300 shares $114,884.00 No Change1.1%0.1 $3.08 GDTC Short Interest - Frequently Asked Questions What is CytoMed Therapeutics' current short interest? Short interest is the volume of CytoMed Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 42,900 shares of GDTC short. 1.08% of CytoMed Therapeutics' shares are currently sold short. Learn More on CytoMed Therapeutics' current short interest. What is a good short interest ratio for CytoMed Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GDTC shares currently have a short interest ratio of 3.0. Learn More on CytoMed Therapeutics's short interest ratio. What is a good short interest percentage for CytoMed Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.08% of CytoMed Therapeutics' floating shares are currently sold short. Is CytoMed Therapeutics' short interest increasing or decreasing? CytoMed Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 42,900 shares, an increase of 8.9% from the previous total of 39,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is CytoMed Therapeutics' float size? CytoMed Therapeutics currently has issued a total of 10,940,000 shares. Some of CytoMed Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CytoMed Therapeutics currently has a public float of 3,960,000 shares. How does CytoMed Therapeutics' short interest compare to its competitors? 1.08% of CytoMed Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to CytoMed Therapeutics: Cumberland Pharmaceuticals Inc. (0.23%), Bullfrog AI Holdings, Inc. (3.62%), Benitec Biopharma Inc. (6.27%), TherapeuticsMD, Inc. (0.46%), Aptorum Group Limited (0.50%), MEI Pharma, Inc. (0.37%), RenovoRx, Inc. (0.19%), Orgenesis Inc. (0.84%), Lumos Pharma, Inc. (6.09%), Lisata Therapeutics, Inc. (0.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short CytoMed Therapeutics stock? Short selling GDTC is an investing strategy that aims to generate trading profit from CytoMed Therapeutics as its price is falling. GDTC shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CytoMed Therapeutics? A short squeeze for CytoMed Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GDTC, which in turn drives the price of the stock up even further. How often is CytoMed Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GDTC, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: CPIX Short Interest BFRG Short Interest BNTC Short Interest TXMD Short Interest APM Short Interest MEIP Short Interest RNXT Short Interest ORGS Short Interest LUMO Short Interest LSTA Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GDTC) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCharles Payne Demystifies OptionsUnstoppable ProsperityTop 5 Tech Stocks to Buy for 2024Daily Market Alerts